Nav: Home

Eliminating HIV is possible; UCLA, Danish researchers explain how

May 09, 2016

Worldwide, about 35 million people are living with HIV. The World Health Organization and the Joint United Nations Programme on HIV/AIDS plan to use an approach called "treatment as prevention" to eliminate the global pandemic, which the WHO says will have occurred when only one person out of 1,000 becomes infected each year.

Now, a nearly two-decade analysis by researchers from UCLA and Denmark yields the first proof that the approach could work.

Reviewing Danish medical records, they found that the treatment-as-prevention strategy has brought Denmark's HIV epidemic to the brink of elimination. The study found that in 2013, the country had only 1.4 new HIV infections per 1,000 men who have sex with men, Denmark's major risk group.

"The Danes have done what nobody else in the world has been able to do," said Sally Blower, the study's senior author and the director of the Center for Biomedical Modeling at UCLA. "They have almost eliminated their HIV epidemic, and they have achieved this simply by providing treatment."

The paper notes, however, that the treatment programs in Denmark are exceptional. "Treatment makes people less infectious," said Justin Okano, the study's lead author and a statistician in Blower's research group. "In Denmark, 98 percent of patients take all of their HIV medications, which is why treatment as prevention has worked there. Unfortunately, adherence levels are nowhere near as high in other countries."

The findings, which appear online May 9 in the Lancet Infectious Diseases, are based on a sophisticated statistical analysis of data from the ongoing Danish HIV Cohort Study, which began in 1995. That project, which tracks all Danish men who have sex with men, and who have been diagnosed with HIV, was established and is run by Jan Gerstoft and Niels Obel, clinicians and epidemiologists in Denmark who also are co-authors of the new study.

For the current study, the researchers used an approach called CD4-staged Bayesian back-calculation to determine the number of Danish men who have sex with men, and who had become infected with HIV each year between 1995 and 2013. They found that the number of infections has been decreasing since 1996, when effective HIV treatments were introduced in Denmark. They then measured the correlation between the decrease in the number of HIV infections each year and the increase in the number of people who began treatment, and they found that the two were highly correlated.

"What we found was very exciting," said Laurence Palk, a co-author of the study and a postdoctoral fellow in Blower's lab. "Our results show treatment as prevention has been slowly but steadily working to end the Danish epidemic."

The team calculated that by 2013, when the epidemic was close to elimination, there were only approximately 600 men in Denmark who have sex with men, and who were infected with HIV but had not been diagnosed.

"Now that the number is so low, it would be fairly easy to do a social media campaign and get these men to be tested," Palk said. "If they accepted treatment, it would essentially end this epidemic."

Blower, who also is a professor in residence at the Semel Institute for Neuroscience and Human Behavior, said, "Over 15 years ago, we made predictions based on mathematical models that treatment as prevention could work and be an effective elimination tool. It's wonderful to see that this has actually happened."

The researchers chalk up Denmark's success to many factors, including the country's universal health care system and the availability of free treatment for all people who have been infected with HIV. However, the largest number of people with HIV -- 25 million -- live in sub-Saharan Africa, where health care systems are overextended and there are far fewer resources.

Blower said that for the treatment-as-prevention approach to eliminate HIV epidemics throughout the world, all countries would need to emulate Denmark's treatment programs.

"Even in resource-rich countries, this would take a huge amount of money and effort," she said. "The goal of elimination through treatment is aspirational, but Denmark has shown that -- at least in resource-rich countries -- it's achievable."
-end-
Danielle Robbins, a postdoctoral fellow in Blower's research group at the time the study was conducted, was the paper's co-first author. The research was funded by National Institutes of Health's National Institute of Allergy and Infectious Diseases.

University of California - Los Angeles

Related Hiv Articles:

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).
Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.
Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.
The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.
The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.
Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.
NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
First ever living donor HIV-to-HIV kidney transplant
For the first time, a person living with HIV has donated a kidney to a transplant recipient also living with HIV.
The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.
Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.
More HIV News and HIV Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.